These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 34224699
1. Dapagliflozin attenuates steatosis in livers of high-fat diet-induced mice and oleic acid-treated L02 cells via regulating AMPK/mTOR pathway. Luo J, Sun P, Wang Y, Chen Y, Niu Y, Ding Y, Xu N, Zhang Y, Xie W. Eur J Pharmacol; 2021 Sep 15; 907():174304. PubMed ID: 34224699 [Abstract] [Full Text] [Related]
2. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway. Zhang J, Du H, Shen M, Zhao Z, Ye X. J Immunol Res; 2020 Sep 15; 2020():3413186. PubMed ID: 32884949 [Abstract] [Full Text] [Related]
4. Vine tea total flavonoids activate the AMPK/mTOR pathway to amelioration hepatic steatosis in mice fed a high-fat diet. Wang C, Yang F, Zeng W, Chen X, Qiu Z, Wang Q, Meng Y, Zheng G, Hu J. J Food Sci; 2024 May 15; 89(5):3019-3036. PubMed ID: 38517018 [Abstract] [Full Text] [Related]
5. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. Quan HY, Kim DY, Kim SJ, Jo HK, Kim GW, Chung SH. Biochem Pharmacol; 2013 May 01; 85(9):1330-40. PubMed ID: 23435355 [Abstract] [Full Text] [Related]
6. Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice. Omori K, Nakamura A, Miyoshi H, Takahashi K, Kitao N, Nomoto H, Kameda H, Cho KY, Takagi R, Hatanaka KC, Terauchi Y, Atsumi T. Metabolism; 2019 Sep 01; 98():27-36. PubMed ID: 31202833 [Abstract] [Full Text] [Related]
8. Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet. Zhu B, Mei W, Jiao T, Yang S, Xu X, Yu H, Ding Y, Guo S, Meng B, Zhao L, He M, Dong K, Guo H, Guo X, Zhang H, Dang R, Xiang G, Wen N. Eur J Pharmacol; 2020 Oct 05; 884():173350. PubMed ID: 32726654 [Abstract] [Full Text] [Related]
9. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways. You L, Wang T, Li W, Zhang J, Zheng C, Zheng Y, Li S, Shang Z, Lin J, Wang F, Qian Y, Zhou Z, Kong X, Gao Y, Sun X. J Ethnopharmacol; 2024 Jul 15; 329():118165. PubMed ID: 38588984 [Abstract] [Full Text] [Related]
10. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway. Shi C, Xue W, Han B, Yang F, Yin Y, Hu C. Eur J Pharmacol; 2019 May 05; 850():15-22. PubMed ID: 30753863 [Abstract] [Full Text] [Related]
11. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway. He Q, Sha S, Sun L, Zhang J, Dong M. Biochem Biophys Res Commun; 2016 Aug 05; 476(4):196-203. PubMed ID: 27208776 [Abstract] [Full Text] [Related]
12. Dapagliflozin dampens liver fibrosis induced by common bile duct ligation in rats associated with the augmentation of the hepatic Sirt1/AMPK/PGC1α/FoxO1 axis. Hassan HA, Nageeb MM, Mohammed HO, Samy W, Fawzy A, Afifi R, Abbas NAT. Toxicol Appl Pharmacol; 2024 Aug 05; 489():116991. PubMed ID: 38871090 [Abstract] [Full Text] [Related]
13. Red Pepper Seeds Inhibit Hepatic Lipid Accumulation by Inducing Autophagy via AMPK Activation. Lee YH, Kim HJ, You M, Kim HA. Nutrients; 2022 Oct 12; 14(20):. PubMed ID: 36296933 [Abstract] [Full Text] [Related]
16. Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice. Iwamoto Y, Kimura T, Dan K, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Shimoda M, Nogami Y, Shirakiya Y, Nakanishi S, Mune T, Kaku K, Kaneto H. Diabetes Obes Metab; 2024 Jun 12; 26(6):2339-2348. PubMed ID: 38504118 [Abstract] [Full Text] [Related]
17. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase. Kim YJ, Hwang SH, Jia Y, Seo WD, Lee SJ. Food Res Int; 2017 Nov 12; 101():209-217. PubMed ID: 28941686 [Abstract] [Full Text] [Related]
20. The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease. Wu H, Zhou M, Jin Q, Wang X, Xu Y, Li M, Chen S, Tang Q, Wang Q, Hu B, Wu H, Xiao M, Qu L, Zhang Q, Liu J. Hepatol Int; 2024 Aug 12; 18(4):1144-1157. PubMed ID: 38184503 [Abstract] [Full Text] [Related] Page: [Next] [New Search]